Overview
U.S. healthcare REIT's Q1 net income attributable to common stockholders turned to a loss yr/yr
Core FFO per share was unchanged from prior year period
Company cut quarterly dividend by about 36% to fund growth strategy
Outlook
Company withdraws 2026 guidance amid portfolio transition and capital redeployment
Result Drivers
SAME-PROPERTY NOI GROWTH - Same-property cash NOI grew 3.2% yr/yr, reflecting stable property-level performance
CAPITAL ALLOCATION SHIFT - Co emphasized a disciplined capital allocation strategy, recycling capital into higher-return investments, per CEO Mark Decker, Jr.
PORTFOLIO OCCUPANCY - Portfolio leased occupancy remained high at 95.4% at quarter end
Company press release: ID:nBw5YGFlsa
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Rental Revenue
$38.02 mln
Q1 Net Income Attributable to Stockholders
-$749,000 mln
Q1 Adjusted FFO
$16.02 mln
Q1 FFO
$14.06 mln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the specialized reits peer group is "buy"
Wall Street's median 12-month price target for Chiron Real Estate Inc is $42.00, about 18.8% above its May 5 closing price of $35.36
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)